High-flow nasal cannula oxygen therapy in patients undergoing thoracic surgery: current evidence and practice

Jakob Wittenstein, Lorenzo Ball, Paolo Pelosi, Marcelo Gama de Abreu

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

PURPOSE OF REVIEW: Patients undergoing thoracic surgery are at high risk for pulmonary and extra pulmonary complications, and may develop impairment of gas exchange during surgery and in the postoperative period. This review focuses on the potential benefits of high-flow nasal cannula (HFNC) oxygen therapy in those patients. RECENT FINDINGS: HFNC oxygen therapy can be used pre, intra and postoperatively. However, evidence for the use of HFNC oxygen therapy is still limited. Most trials investigated the effects of HFNC oxygen therapy in the postoperative period only, with promising beneficial effects. Preoperative HFNC oxygen therapy might be an alternative to conventional techniques, and allows continuous oxygenation during the apneic time of laryngoscopy. In certain patients, thoracic surgery might be performed in awake and nonintubated patients who are breathing spontaneously. Under these conditions, HFNC oxygen therapy might be considered for respiratory support by experienced anesthesiologists. In the postoperative period, HFNC oxygen therapy can prevent escalation of respiratory management and has the potential to reduce the length of hospital stay. Throughout the perioperative period, close monitoring of patients receiving HFNC oxygen therapy is key, and intubation criteria to avoid delayed intubation should be defined a priori to prevent harm. SUMMARY: HFNC oxygen therapy is a promising tool in the perioperative care of thoracic surgical patients, when properly set, performed by experienced staff and closely monitored.

Original languageEnglish
Pages (from-to)44-49
Number of pages6
JournalCurrent Opinion in Anaesthesiology
Volume32
Issue number1
DOIs
Publication statusPublished - Feb 1 2019

Fingerprint

Thoracic Surgery
Oxygen
Postoperative Period
Therapeutics
Intubation
Length of Stay
Perioperative Care
Cannula
Lung
Laryngoscopy
Perioperative Period
Physiologic Monitoring
Respiration
Thorax
Gases

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

High-flow nasal cannula oxygen therapy in patients undergoing thoracic surgery : current evidence and practice. / Wittenstein, Jakob; Ball, Lorenzo; Pelosi, Paolo; Gama de Abreu, Marcelo.

In: Current Opinion in Anaesthesiology, Vol. 32, No. 1, 01.02.2019, p. 44-49.

Research output: Contribution to journalReview article

@article{acf10e59b61f436082f3be184f55905f,
title = "High-flow nasal cannula oxygen therapy in patients undergoing thoracic surgery: current evidence and practice",
abstract = "PURPOSE OF REVIEW: Patients undergoing thoracic surgery are at high risk for pulmonary and extra pulmonary complications, and may develop impairment of gas exchange during surgery and in the postoperative period. This review focuses on the potential benefits of high-flow nasal cannula (HFNC) oxygen therapy in those patients. RECENT FINDINGS: HFNC oxygen therapy can be used pre, intra and postoperatively. However, evidence for the use of HFNC oxygen therapy is still limited. Most trials investigated the effects of HFNC oxygen therapy in the postoperative period only, with promising beneficial effects. Preoperative HFNC oxygen therapy might be an alternative to conventional techniques, and allows continuous oxygenation during the apneic time of laryngoscopy. In certain patients, thoracic surgery might be performed in awake and nonintubated patients who are breathing spontaneously. Under these conditions, HFNC oxygen therapy might be considered for respiratory support by experienced anesthesiologists. In the postoperative period, HFNC oxygen therapy can prevent escalation of respiratory management and has the potential to reduce the length of hospital stay. Throughout the perioperative period, close monitoring of patients receiving HFNC oxygen therapy is key, and intubation criteria to avoid delayed intubation should be defined a priori to prevent harm. SUMMARY: HFNC oxygen therapy is a promising tool in the perioperative care of thoracic surgical patients, when properly set, performed by experienced staff and closely monitored.",
author = "Jakob Wittenstein and Lorenzo Ball and Paolo Pelosi and {Gama de Abreu}, Marcelo",
year = "2019",
month = "2",
day = "1",
doi = "10.1097/ACO.0000000000000682",
language = "English",
volume = "32",
pages = "44--49",
journal = "Current Opinion in Anaesthesiology",
issn = "0952-7907",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - High-flow nasal cannula oxygen therapy in patients undergoing thoracic surgery

T2 - current evidence and practice

AU - Wittenstein, Jakob

AU - Ball, Lorenzo

AU - Pelosi, Paolo

AU - Gama de Abreu, Marcelo

PY - 2019/2/1

Y1 - 2019/2/1

N2 - PURPOSE OF REVIEW: Patients undergoing thoracic surgery are at high risk for pulmonary and extra pulmonary complications, and may develop impairment of gas exchange during surgery and in the postoperative period. This review focuses on the potential benefits of high-flow nasal cannula (HFNC) oxygen therapy in those patients. RECENT FINDINGS: HFNC oxygen therapy can be used pre, intra and postoperatively. However, evidence for the use of HFNC oxygen therapy is still limited. Most trials investigated the effects of HFNC oxygen therapy in the postoperative period only, with promising beneficial effects. Preoperative HFNC oxygen therapy might be an alternative to conventional techniques, and allows continuous oxygenation during the apneic time of laryngoscopy. In certain patients, thoracic surgery might be performed in awake and nonintubated patients who are breathing spontaneously. Under these conditions, HFNC oxygen therapy might be considered for respiratory support by experienced anesthesiologists. In the postoperative period, HFNC oxygen therapy can prevent escalation of respiratory management and has the potential to reduce the length of hospital stay. Throughout the perioperative period, close monitoring of patients receiving HFNC oxygen therapy is key, and intubation criteria to avoid delayed intubation should be defined a priori to prevent harm. SUMMARY: HFNC oxygen therapy is a promising tool in the perioperative care of thoracic surgical patients, when properly set, performed by experienced staff and closely monitored.

AB - PURPOSE OF REVIEW: Patients undergoing thoracic surgery are at high risk for pulmonary and extra pulmonary complications, and may develop impairment of gas exchange during surgery and in the postoperative period. This review focuses on the potential benefits of high-flow nasal cannula (HFNC) oxygen therapy in those patients. RECENT FINDINGS: HFNC oxygen therapy can be used pre, intra and postoperatively. However, evidence for the use of HFNC oxygen therapy is still limited. Most trials investigated the effects of HFNC oxygen therapy in the postoperative period only, with promising beneficial effects. Preoperative HFNC oxygen therapy might be an alternative to conventional techniques, and allows continuous oxygenation during the apneic time of laryngoscopy. In certain patients, thoracic surgery might be performed in awake and nonintubated patients who are breathing spontaneously. Under these conditions, HFNC oxygen therapy might be considered for respiratory support by experienced anesthesiologists. In the postoperative period, HFNC oxygen therapy can prevent escalation of respiratory management and has the potential to reduce the length of hospital stay. Throughout the perioperative period, close monitoring of patients receiving HFNC oxygen therapy is key, and intubation criteria to avoid delayed intubation should be defined a priori to prevent harm. SUMMARY: HFNC oxygen therapy is a promising tool in the perioperative care of thoracic surgical patients, when properly set, performed by experienced staff and closely monitored.

UR - http://www.scopus.com/inward/record.url?scp=85059227301&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059227301&partnerID=8YFLogxK

U2 - 10.1097/ACO.0000000000000682

DO - 10.1097/ACO.0000000000000682

M3 - Review article

C2 - 30543553

AN - SCOPUS:85059227301

VL - 32

SP - 44

EP - 49

JO - Current Opinion in Anaesthesiology

JF - Current Opinion in Anaesthesiology

SN - 0952-7907

IS - 1

ER -